Plant Growers Australia PTY. Ltd.
USPTO PatentsView assignee record - 16 granted patents across 0 technology areas, recorded in grant years 2018–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.
The verdict
According to USPTO PatentsView, Plant ranks #18,000 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 0 technology areas.
- #18,000
- of 49,997 US assignees by volume
- 34th percentile
- by Innovation Score (30.4/100)
- 1.0
- avg claims per patent
- +150%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R18000 · Foreign Corporation #18,000 · 16 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-THIN · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-SURGE · BOOK-RICH
- GRANTS-MICRO 16 grants
- MID-PACK #18,000/49,997
- PHOTO-FINISH PGI Drug Discovery
- CPC-UNK CPC blank
- INNOV-THIN 30.4/100
- CLAIMS-SPARSE 1.0 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +150% vel
- BOOK-RICH 9/10 fields
Nearest grant-volume peer: PGI Drug Discovery LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Plant’s 30.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Plant
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Plant Growers… · this assignee 30
Plant Growers… · this assignee
30 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Plant's Innovation Score is 30.4/100 (34th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Plant?
Each dot is one of Plant’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Plant’s own 1.0 claims/patent is at or below the 14.4 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Plant's grants concentrate
Plant Growers Australia PTY. Ltd. is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2023 (10 grants) versus a trough of 2 in 2018. By volume, Plant sits between PGI Drug Discovery LLC and Polin SU Parklari VE Havuz Sistemleri Anonim Sirketi.
Plant's three-year grant acceleration
Plant Growers Australia PTY. Ltd. shows 10 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Plant's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- PGI Drug Discovery
PGI Drug Discovery LLC
16 patents
- Pgytech
Pgytech Co., Ltd.
16 patents
- Pharma MAR
Pharma MAR, S.A.
16 patents
- Pkware
Pkware, Inc.
16 patents
- Plant Health Care
Plant Health Care, Inc.
16 patents
- Plastic Omnium NE…
Plastic Omnium NEW Energies France
16 patents
- PLX
PLX, Inc.
16 patents
- Polin SU Parklari…
Polin SU Parklari VE Havuz Sistemleri Anonim Sirketi
16 patents
- Plant Growers Aus… ◀
Plant Growers Australia PTY. Ltd.
16 patents
What this shows Plant holds 16 patents at rank #17,986, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Plant
By rank, the assignees closest to #17,986 in granted patent volume.
- PGI Drug Discovery LLC #17,982 · 16 patents
- Pgytech Co., Ltd. #17,983 · 16 patents
- Pharma MAR, S.A. #17,984 · 16 patents
- Pkware, Inc. #17,985 · 16 patents
- Plant Health Care, Inc. #17,987 · 16 patents
- Plastic Omnium NEW Energies France #17,988 · 16 patents
- PLX, Inc. #17,989 · 16 patents
- Polin SU Parklari VE Havuz Sistemleri Anonim Sirketi #17,990 · 16 patents
Plant's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
30 34th percentile higher than 34% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2018 | 2 | 12.5% |
| 2019 | 2 | 12.5% |
| 2023 | 10 | 62.5% |
| 2025partial year | 2 | 12.5% |
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Plant Growers Australia PTY. Ltd.'s patent record in context - here's where to go next.
- Ranked #18,000 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Plant Growers Australia PTY. Ltd. against PGI Drug Discovery LLC, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 30.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.